Acurx Pharmaceuticals LLC Earnings

The next earnings date for Acurx Pharmaceuticals LLC is November 18, 2025.

They are scheduled to announce earnings after the market closes that day.

Analyst Estimates of Acurx Pharmaceuticals LLC Earnings

Report DateEstimated Earnings Per Share
11/18/2025$-0.15

What is an Earnings Date

An earnings date is typically considered to be the date that a company publicly announces its earnings. Many companies in the US stock market do earnings announcements once per quarter.

Earnings announcements are typically accompanied by commentary from the company that explains the earnings performance and speaks to future earnings prospects.

Earnings announcements can cause a company’s stock price to change abruptly, so earnings dates are closely monitored by some investors.

Acurx Pharmaceuticals LLC Earnings: Historical

Report DateBefore/After MarketEarnings Per ShareSurprise %
08/12/2025---$-1.89-950.00%
05/13/2025Before Market$-0.1121.43%
03/17/2025Before Market------
11/13/2024Before Market$-0.1715.00%
08/08/2024After Market$-0.26-18.18%
05/14/2024After Market$-0.28-16.67%
03/15/2024After Market$-0.37-42.31%
11/13/2023After Market$-0.2411.11%
08/11/2023After Market$-0.28-3.70%
05/12/2023Before Market$-0.2513.79%
03/15/2023After Market$-0.2820.00%
11/10/2022After Market$-0.32-14.29%
08/12/2022After Market$-0.2621.21%
05/10/2022After Market$-0.2621.21%
03/16/2022After Market$-0.2245.00%
11/12/2021After Market$-0.2154.35%
08/13/2021After Market$-0.57---
06/28/2021Before Market$-0.48---
03/31/2021---$-0.11---
09/30/2020---$-0.21---
06/30/2020---$-0.15---

More About Acurx Pharmaceuticals LLC

Country
USA
Full Time Employees
4

Acurx Pharmaceuticals, Inc., a clinical stage biopharmaceutical company, develops antibiotics to treat bacterial infections in the United States. The company's lead antibiotic candidate is ibezapolstat, a novel mechanism of action that targets the polymerase IIIC enzyme that is in Phase 2b clinical trial to treat patients with clostridium difficile infections. It also develops ACX-375C, a potential oral and parenteral treatment targeting gram-positive bacteria, including methicillin-resistant staphylococcus aureus, vancomycin-resistant enterococcus, and penicillin-resistant streptococcus pneumonia; and CCP, multiple product candidates for gram-positive infections. Acurx Pharmaceuticals, Inc. was incorporated in 2017 and is headquartered in Staten Island, New York.

Acurx Pharmaceuticals LLC Earnings” Can Refer to the Acurx Pharmaceuticals LLC Earnings Date

Some people say “Acurx Pharmaceuticals LLC earnings” as a shortform way to refer to the earnings date.

For example, someone might say, “I plan to hold my Acurx Pharmaceuticals LLC position through earnings.” That typically means the person is going to hold their position through the upcoming earnings date.

Owning Acurx Pharmaceuticals LLC Stock on the Earnings Date

If you own Acurx Pharmaceuticals LLC stock (ACXP) on the earnings date, then you will be exposed to the potential price volatility that often accompanies earnings announcements.

A company’s earnings typically have a big impact on its stock price, which explains why the stock price for Acurx Pharmaceuticals LLC might exhibit major fluctuations on the day of the earnings announcement. The price fluctuations can go in either direction (up or down), representing a larger potential investment risk and reward than many other days of the year.

There is often a big audience of investors involved with trading Acurx Pharmaceuticals LLC shares of stock on its earnings day. This means there is typically more trading volume, liquidity, and price volatility on the day earnings are announced.

These features are attractive to some types of active traders who are looking for stocks that exhibit large price movements and substantial volume.

Learning More Acurx Pharmaceuticals LLC Earnings

You can contact us any time if you would like to ask questions about Acurx Pharmaceuticals LLC earnings or anything else related to the stock market.